PGNY News and Press, Progyny Inc. From 06/04/24

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Glo...

2024-06-03 22:01:08 ET Summary PGNY experienced a revenue miss in 1Q24 due to weak utilization. Historical data shows that IVF demand has been resilient, with strong rebounds following economic downturns. Leading indicators suggest that utilization rates are already improving,...

2024-05-23 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-22 17:04:42 ET More on Progyny Progyny: Long-Term Outlook Remains Positive, Reiterate Buy Progyny tumbles 22% amid Q1 report, KeyBanc downgrade Progyny Non-GAAP EPS of $0.39 beats by $0.05, revenue of $278.08M misses by $11.01M Read the full article...

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common sto...

2024-05-17 09:00:09 ET Jailendra Singh from Truist Financial issued a price target of $37.00 for PGNY on 2024-05-17 07:46:00. The adjusted price target was set to $37.00. At the time of the announcement, PGNY was trading at $27.55. The overall price target consensus is a...

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Progyny’s executives will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference...

2024-05-12 09:45:00 ET Summary Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. In the first quarter of 2024, the Polen Capital U.S. SMID Company Growth Composite Portfolio return...

2024-05-12 09:35:00 ET Summary Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. In the first quarter, the Polen Capital U.S. Small Company Growth Composite Portfolio (the “...

A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 98.7% to $8.88 on volume of 168,692,127 shares AEye Inc. (LIDR) rose 115.0% to $2.58 on volume of 156,236,079 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 17.3% to $0.7609 on volume of 123,678,040 s...